ArticlePharmaceutical research2026

Integrative In-silico, Network Pharmacology, Pharmacogenomics and In-vitro Evaluation of Fulvestrant-Loaded Zinc Oxide Nanoparticles Targeting HER2 Positive Breast Cancer.

Melphiya D et al.PubMed ↗Publisher ↗

No numbers read from the abstract.